智通财经APP获悉，周五，Alamar Biosciences(ALMR.US)登陆美股市场，开盘涨超34%，报22.91美元。IPO价格为17美元。Alamar Biosciences是一家总部位于美国加州的生物科技公司，专注于精准蛋白质组学技术的开发与应用。公司核心产品基于自研的NULISA平台，能够以极高灵敏度检测血液中的微量蛋白质标志物，从而帮助科研人员更早发现疾病、推动药物研发和精准医疗发展。其技术主要应用于阿尔茨海默症、帕金森等神经退行性疾病研究领域。
智通财经APP获悉，周五，Alamar Biosciences(ALMR.US)登陆美股市场，开盘涨超34%，报22.91美元。IPO价格为17美元。Alamar Biosciences是一家总部位于美国加州的生物科技公司，专注于精准蛋白质组学技术的开发与应用。公司核心产品基于自研的NULISA平台，能够以极高灵敏度检测血液中的微量蛋白质标志物，从而帮助科研人员更早发现疾病、推动药物研发和精准医疗发展。其技术主要应用于阿尔茨海默症、帕金森等神经退行性疾病研究领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.